NEW YORK (GenomeWeb News) – Life Technologies said today that it has agreed to acquire AcroMetrix for an undisclosed amount.
AcroMetrix, based in Benicia, Calif., provides molecular and serological diagnostic quality control products to clinical laboratories, blood screening centers, and in vitro diagnostic manufacturers.
"With the growth of DNA- and other molecular-based tests, there is a growing need for high-quality, independently provided controls to ensure the accuracy and integrity of laboratory test results," Life Tech CEO Greg Lucier said in a statement.
Life Tech said that its molecular diagnostics product portfolio is responsible for some $300 million of the company's annual revenues, and includes technologies such as magnetic beads, fluorescent dyes, and antibodies; as well as products such as the SPOT-Light HER2 CISH kit for breast cancer; Dynachip system for automated HLA antibody screening; and various molecular diagnostic instruments.
"The acquisition of AcroMetrix builds on our substantial business of providing tools and technologies into the molecular diagnostics industry," Lucier added.
Life Tech said that the transaction is not expected to have a material effect on its financials in fiscal year 2010.